| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.4 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.25 |
0.4 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
| mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
0.13 |
0.4 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
| mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |